Literature DB >> 3023790

[Late neurologic syndrome in patients with Argentinian hemorrhagic fever treated with immune plasma].

D A Enria, A J de Damilano, A M Briggiler, A M Ambrosio, N J Fernández, M R Feuillade, J I Maiztegui.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3023790

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


× No keyword cloud information.
  6 in total

1.  The glycoprotein precursor gene of Junin virus determines the virulence of the Romero strain and the attenuation of the Candid #1 strain in a representative animal model of Argentine hemorrhagic fever.

Authors:  Alexey V Seregin; Nadezhda E Yun; Milagros Miller; Judith Aronson; Jennifer K Smith; Aida G Walker; Jeanon N Smith; Cheng Huang; John T Manning; Juan C de la Torre; Slobodan Paessler
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

Review 2.  Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.

Authors:  Sheli R Radoshitzky; Jens H Kuhn; Fabian de Kok-Mercado; Peter B Jahrling; Sina Bavari
Journal:  Expert Opin Drug Discov       Date:  2012-05-19       Impact factor: 6.098

3.  MMV-db: vaccinomics and RNA-based therapeutics database for infectious hemorrhagic fever-causing mammarenaviruses.

Authors:  Taimoor Khan; Abbas Khan; Dong-Qing Wei
Journal:  Database (Oxford)       Date:  2021-10-22       Impact factor: 3.451

Review 4.  Commentary: Convalescent plasma to treat COVID-19: Following the Argentinian lead.

Authors:  Pierre Tiberghien; Eric Toussirot; Pascale Richard; Pascal Morel; Olivier Garraud
Journal:  Transfus Apher Sci       Date:  2021-05-23       Impact factor: 1.764

5.  Reactive astrogliosis in response to hemorrhagic fever virus: microarray profile of Junin virus-infected human astrocytes.

Authors:  Olga A Kolokoltsova; Nadezhda E Yun; Slobodan Paessler
Journal:  Virol J       Date:  2014-07-11       Impact factor: 4.099

Review 6.  Treatment of Argentine hemorrhagic fever.

Authors:  Delia A Enria; Ana M Briggiler; Zaida Sánchez
Journal:  Antiviral Res       Date:  2007-11-20       Impact factor: 5.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.